Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-28T12:56:23.485Z Has data issue: false hasContentIssue false

Bancroftian filariasis: a 13-year follow-up study of asymptomatic microfilariae carriers and endemic normals in Orissa, India

Published online by Cambridge University Press:  30 July 2002

P. K. SAHOO
Affiliation:
Division of Immunology, Regional Medical Research Centre, ICMR, Bhubaneswar, Orissa, India
J. J. BABU GEDDAM
Affiliation:
Division of Immunology, Regional Medical Research Centre, ICMR, Bhubaneswar, Orissa, India
A. K. SATAPATHY
Affiliation:
Division of Immunology, Regional Medical Research Centre, ICMR, Bhubaneswar, Orissa, India
M. C. MOHANTY
Affiliation:
Division of Immunology, Regional Medical Research Centre, ICMR, Bhubaneswar, Orissa, India
B. K. DAS
Affiliation:
Department of Medicine, SCB Medical College, Cuttack, Orissa, India
A. S. ACHARYA
Affiliation:
Division of Epidemiology, Regional Medical Research Centre, ICMR, Bhubaneswar, Orissa, India
N. MISHRA
Affiliation:
Homeopathic Research Institute for Filariasis, Puri, Orissa, India
B. RAVINDRAN
Affiliation:
Division of Immunology, Regional Medical Research Centre, ICMR, Bhubaneswar, Orissa, India

Abstract

The natural history of human filarial infections leading to development of disease has been a subject of intense debate. The models proposed so far have largely been based on cross-sectional data on microfilariae (Mf) and disease prevalence in filariasis endemic areas. In an attempt to study the parasitological and clinical consequences of filarial infection in Beldal (Orissa, India), an area endemic for Bancroftian filariasis, cohorts of 59 asymptomatic Mf carriers (AS) and 187 asymptomatic and amicrofilaraemic subjects or ‘endemic normals’ (‘EN’), were followed-up and a fraction (73% and 46% respectively) re-examined after 13 years to monitor (a) Mf prevalence, (b) Mf density, (c) circulating filarial antigen (CFA) and (d) chronic disease manifestations. The Mf prevalence and density were also monitored in Mf carriers after 1 and 4 years. Both Mf prevalence and density decreased progressively in the cohort of Mf carriers over a period of 13 years in Beldal. Only 37% of them continued to be microfilaraemic and the Mf density in these subjects was only 10% of the original level. However, loss of circulating Mf in this cohort did not result in loss of CFA and 95% remained CFA positive regardless of Mf status. About 23% of males in the ‘EN’ cohort developed hydrocoele while only 5·7% of male Mf carriers, who were not treated with DEC, had developed hydrocoele after 13 years. A cohort of Mf carriers in another area, Jatni, was also examined after 10 years to study the parasitological and clinical outcome. In this area, about 59% of the Mf carriers continued to be microfilaraemic after 10 years. These results reveal that in Mf carriers adult filarial worms persist for several years and that loss of circulating Mf with or without chemotherapy with DEC (single 12-day course) does not influence adult worm survival. The findings have been discussed in the context of ‘static’ and ‘dynamic’ models describing the relationship between infection and disease in human filariasis.

Type
Research Article
Copyright
2002 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)